Patent Application Titled "Anti-Gal3 Antibody Formulations And Methods Of Use Thereof" Published Online (USPTO 20240158512).

The patent application titled "Anti-Gal3 Antibody Formulations And Methods Of Use Thereof" describes the development of pharmaceutical antibody formulations containing an anti-Gal3 antibody. These formulations have specific sequences of heavy and light chain CDRs and include additional components such as histidine, methionine, NaCl, and polysorbate. The formulations have a pH range of 5.3 to 6.3 and are intended for the treatment of Alzheimer's disease. The patent application provides detailed information on the composition and dosage of these formulations, as well as the sequences of the antibody's variable domains and their encoding nucleic acid sequences. For more information, please consult the full patent application. [Extracted from the article]